Vaccines comprising synthetic genes
Abstract
Synthetic polynucleotides comprising a DNA sequence encoding a peptide or protein are provided. The DNA sequence of the synthetic polynucleotides comprise codons optimized for expression in a nonhomologous host. The invention is exemplified by synthetic DNA molecules encoding HIV env as well as modifications of HIV env. The codons of the synthetic molecules include the projected host cell's preferred codons. The synthetic molecules provide preferred forms of foreign genetic material. The synthetic molecules may be used as a polynucleotide vaccine which provides immunoprophylaxis against HIV infection through neutralizing antibody and cell-mediated immunity. This invention provides polynucleotides which, when directly introduced into a vertebrate in vivo, including mammals such as primates and humans, induces the expression of encoded proteins within the animal.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A synthetic polynucleotide comprising a DNA sequence encoding a peptide or protein, the DNA sequence comprising codons optimized for expression in a nonhomologous host.Join the waitlist — get patent alerts
Track US2003229214A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.